GSK3B and muscular atrophy: A kinase-inactive form of GSK-3β and pharmacological inhibition of GSK-3β induce hypertrophy (Rommel et al., 2001; Vyas et al., 2002) and have been applied as interventions for skeletal muscle atrophy (Verhees et al., 2011).